FAEGRE DRINKER BIDDLE & REATH LLP for ALLIANCE FOR BIOSECURITY
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
S. 2055 Medical Countermeasure Innovations Act of 2015 provision regarding priority review vouchers contracting; H.R. 34 21st Century Cures Act; H.R. 3299, Strengthening Public Health Emergency Response Act of 2016, provisions regarding priority review vouchers contracting.
Foreign entity interest: Bavarian Nordic seeks continued governmental support for biomedical countermeasure efforts that utilize technology they provide.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHIL GINGREY | — |
| MAUREEN HARDWICK | — |
| SARAH T. MILLS | — |
| JIM TWADDELL | — |
Budget/Appropriations BUD
House and Senate 2017 and 2018 Labor, Health and Human Services Appropriations Bills, funding for Biomedical Advanced Research and Development Authority (BARDA), Project BioShield Special Reserve Fund (SRF), Strategic National Stockpile (SNS), pandemic influenza (pan flu), and emerging infectious diseases (EID).
Foreign entity interest: Bavarian Nordic seeks continued funding for biomedical countermeasure efforts that utilize technology they provide.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MAUREEN HARDWICK | — |
| JONATHAN M. HEPPEN | — |
| JULIE HYAMS New | — |
| SARAH T. MILLS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.